|
|
Özet
METHİMAZOLE BAĞLI MYOPATİ VE TOKSİK HEPATİTTE N-ASETİLİSİSTEİN TEDAVİSİNİN ETKİNLİĞİ (OLGU RAPORU)
Anahtar Kelimeler
METHİMAZOLE BAĞLI MYOPATİ VE TOKSİK HEPATİTTE N-ASETİLİSİSTEİN TEDAVİSİNİN ETKİNLİĞİ (OLGU RAPORU)
Kaynakça
1. Larrooy Jameson J L, De Groot L J (Editors). Endocrinology Adult and Pediatric 7.th edition. Philadelphia; Elsevier-Saunders: 2015. p. 1456-7.
2. Arıcı S. Toksik Hepatit. Pamukkale Tıp Dergisi 2008;1:113-9.
3. Karsen H, Çalışır C, Duygu F ve ark. Zayıflama çayı kullanımına bağlı gelişen akut hepatit: Bir Olgu Sunumu. Van Tıp Dergisi 2011;18:110-2.
4. Bonkovsky HL, Jones DP, LaBrecque DR, Shedlofsky S. Drug-Induced Lıver Injury. In: Boyer TD, Wright TL, Manns MP, Editors. Zakim and Boyer’s Hepatology, A Textbook Of Liver Disease. Volume I, 5th,Saunders. Elsevier 2006;503-50.
5. Hu J, Zhang Q, Ren X, Sun Z, Quan Q. Efficacy and safety of acetylcysteine in "nonacetaminophen" acute liver failure: A meta-analysis of prospective clinical trials. Clin Res Hepatol Gastroenterol 2015; 39(5):594-9.
6. Lane RJ, Mastaglia FL. Drug-induced myopatihesin man. Lancet. 1978;2:562-6.
7. Sieb JP, Gillessen T. Iatrojenic and toxic myopathies. Muscle Nerve. 2003; 27:142.
8. Suzuki S, et al. Elevation of serum creatine kinase during treatment with anti-thyroid drugs in patients with hyperthyroidism due to Graves’ disease. A novel side effect of anti-thyroid drugs. Arch Intern Med. 1997;157:693-6.
9. Ito T, Katahira M, Hanakita M, Suzuki. A case of elevation of serum creatine kinase with anti-thyroid medications for Graves’ disease. J Endocrinol Metab. 2012;2:244-7.
10. Mizuno H, et al. Elevation of serum creatine kinase in response to medical treatment of Graves' disease in children. Acta Paediatr. 2006;243-5.
11. Kim H, et al. Elevation of serum creatinine kinase during methimazole treatment of Graves’ disease in a 13-year-old girl and a literature review of similar cases. Ann Pediatr Endocrinol Metab. 2015;20:106-9.
12. Hillman L, Gottfried M, Whitsett M, et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol. 2016;111:958-965.
13.E Arab D, Malatjalian DA, Rittmaster RS.Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 1995;80(4):1083-5.
14.F Blom H, Stolk J, Schreuder HB, et al. A case of carbimazole-induced intrahepatic cholestasis. An immunemediated reaction? Arch Intern Med 1985;145(8):1513-15.
15. Rivkees S, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 2010;95(7):3260-7.
16. Gallelli L, Staltari O, Palleria C, et al. Hepatotoxicity induced by methimazole in a previously healthy patient.Curr Drug Saf 2009;4(3):204-6.
17. Woeber K. Methimazole-induced hepatotoxicity. Endocr Pract 2002;8(3):222-4.
18. Noureddin N., Kaplowitz N. Overview of mechanisms of drug-induced liver injury (DILI) and key challenges in DILI research. In: Chen M., Will Y., editors. DRUG-INDUCED LIVER TOXICITY. METHODS IN PHARMACOLOGY AND TOXICOLOGY. New York, NY, USA: Humana Press; 2018. pp.3–18.
19. Holt M. P. Ju C. Mechanisms of drug-induced liver injury. AAPS JOURNAL. 2006;8(1):48-54.
20.Shen C, Zhao CY, Liu F, et al. Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report. BMC Gastroenterol 2010;10:93.
21.Majeed M, Babu A. Cholestasis secondary to hyperthyroidism made worse by methimazole. Am J Med Sci 2006;332(1):51-3.
22. Hung Y, Yu WK, Chow E. Delayed cholestatic hepatitis due to methimazole.Hong Kong Med J 1999;5(2):200-1.
23. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009;137:856–864.
24. Johnson K, McEvoy CE, Naqvi S, et al. Highdose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis 2016;11:799-807.
25. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous Nacetylcysteine treatment protocol. Ann Emerg Med 1991;20(10):1058–63.
26. Bucaretchi F, Fernandes CB, Branco MM, et al. Acute liver failure in a term neonate after repeated paracetamol administration. Rev Paul Pediatr 2014;32(1):144-8.
27. Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006;44(1):1-18.
28. Mumtaz K, Azam Z, Hamid S, et al. Role of Nacetylcysteine in adults with non-acetaminopheninduced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009; 3(4): 563-70.
29. Saleem AF, Abbas Q, Haque AU. Use of Nacetylcysteine in children with fulminant hepatic failure caused by acute viral hepatitis. J Coll Physicians Surg Pak. 2015; 25(5):354-8.
|
|
